Clinical Trial Update: A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy Japanese men evaluating tolerability of different doses of BI 894416; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• BI 894416

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: TERMINATED | Results posted: 2023-08-16